The University Medical Center Hamburg-Eppendorf, Hamburg (Germany)
3
presentations
0
follower
9
more
presentations
in this session
Fibroblast growth factor-23 (FGF23), an early biomarker of sublinical kidney dysfunction, is associated with poor prognosis in acute coronary syndrome patients